Blog
RSS FeedPosted by Michael Wonder on 28 Oct 2019
NICE to support new valuation study for England for EQ-5D-5L questionnaire
24 October 2019 - Study will measure public’s preference for different health states. ...
Posted by Michael Wonder on 13 Jan 2019
The impact of moving from the EQ-5D-3L to the -5L in NICE technology appraisals
11 January 2019 - The EQ-5D instrument is NICE’s preferred measure of health-related quality of life in adults. ...
Posted by Michael Wonder on 05 Oct 2018
Evaluating progression-free survival as a surrogate outcome for health-related quality of life in oncology
1 October 2018 - Progression-free survival has become a commonly used outcome to assess the efficacy of new cancer drugs. However, ...
Posted by Michael Wonder on 27 Sep 2018
Differentiation of health-related quality of life outcomes between five disease areas: results from an international survey of patients
25 September 2018 - Health-related quality of life data generated by generic, preference-based instruments are highly demanded in health policy decision ...
Posted by Michael Wonder on 13 Jun 2018
Metastatic breast cancer: highly selective post-hoc analysis rather than complete publication of quality of life data
13 June 2018 - IQWiG employees criticise the publication practice of PALOMA-2 study authors. ...
Posted by Michael Wonder on 20 May 2018
3L, 5L, What the L? A NICE conundrum
20 May 2018 - For many years, NICE has recommended use of the EQ-5D-3L and its value set for the UK. ...
Posted by Michael Wonder on 27 Apr 2018
What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews
27 April 2018 - Finch assessed the evidence on the validity and responsiveness of five commonly used preference-based instruments, the ...
Posted by Michael Wonder on 14 Nov 2017
The “utility” in composite outcome measures
14 November 2017 - Measuring what is important to patients. ...
Posted by Michael Wonder on 10 Nov 2017
Quality of life: an important element of treatment value
9 November 2017 - In the era of platinum-based chemotherapy, attempts to improve the quality of life of patients with advanced ...
Posted by Michael Wonder on 28 Oct 2017
In search of a common currency: a comparison of seven EQ-5D-5L value sets
24 October 2017 - The recently published EQ-5D-5L value sets from Canada, England, Japan, Korea, the Netherlands, Spain, and Uruguay are ...
Posted by Michael Wonder on 13 Jun 2017
NICE to work with partners on developing new ways to measure quality of life across health and social care
13 June 2017 - NICE is taking part in a project that will examine how quality of life measures used to ...
Posted by Michael Wonder on 19 Mar 2017
EQ-5D and the EuroQol Group: past, present and future
17 March 2017 - The Office of Health Economics has posted a new item entitled 'EQ-5D and the EuroQol Group: Past, ...
Posted by Michael Wonder on 12 Mar 2017
Four years of early benefit assessment of new drugs in Germany: a qualitative study on methodological requirements for quality of life data
12 March 2017 - This study determined methodological requirements for health-related quality of life measurement and data presentation in the early ...
Posted by Michael Wonder on 15 Feb 2017
Quality of life, overall survival and costs of cancer drugs approved based on surrogate outcomes
14 February 2017 - The lack of evidence of a clinically meaningful benefit for many cancer drugs approved by the US ...
Posted by Michael Wonder on 29 Nov 2016
Quality of life, overall survival, and costs of cancer drugs approved based on surrogate endpoints
29 November 2016 - The lack of evidence of a clinically meaningful benefit for many cancer drugs approved by the US ...